Literature DB >> 33094366

ERAS pathway in colorectal surgery: structured implementation program and high adherence for improved outcomes.

Marco Catarci1,2, Michele Benedetti3, Angela Maurizi4, Francesco Spinelli5, Tonino Bernacconi6, Gianluca Guercioni3, Roberto Campagnacci4.   

Abstract

Although there is clear evidence that an Enhanced Recovery After Surgery (ERAS) program in colorectal surgery leads to significantly reduced morbidity rates and length of hospital stay (LOS), it is still unclear what modalities and levels of implementation of the program are necessary to achieve these results. The purpose of this study is to analyze the methods and results of the first year of structured implementation of a colorectal ERAS program in two surgical units of the Azienda Sanitaria Unica Regionale (ASUR) Marche in Italy. A two-center observational study on a prospectively maintained database was performed on 196 consecutive colorectal resections (excluding emergencies and American Society of Anesthesiologists class > III cases) over a 1-year period. More than 50 variables including adherence to the individual items of the ERAS program were considered. Primary outcomes were overall morbidity, major morbidity, mortality and anastomotic leakage rates; secondary outcomes were LOS, re-admission and re-operation. The results were evaluated by univariate and multivariate analyses through logistic regression. After a median follow-up of 39.5 days, we recorded complications in 72 patients (overall morbidity 36.7%), major complications in 14 patients (major morbidity 7.1%), 6 deaths (mortality 3.1%), anastomotic dehiscence in 9 cases (4.9%), mean overall LOS of 6.6 days, 10 readmissions (5.1%) and 13 reoperations (6.7%). The mean adherence rate to the items of the ERAS program was 85.4%, showing a significant dose-effect curve for overall and major morbidity rates, anastomotic leakage rates and LOS. The implementation methods of a colorectal ERAS program in this study led to a high adherence (> 80%) to the program items. High adherence had significant effects also on major morbidity and anastomotic leakage rates.

Entities:  

Keywords:  Anastomotic leakage; Colorectal surgery; Compliance; ERAS; Major morbidity

Mesh:

Year:  2020        PMID: 33094366     DOI: 10.1007/s13304-020-00885-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  7 in total

1.  Impact of diabetes on postoperative outcomes following colon cancer surgery.

Authors:  Nitasha Anand; Christopher A Chong; Rachel Y Chong; Geoffrey C Nguyen
Journal:  J Gen Intern Med       Date:  2010-03-30       Impact factor: 5.128

Review 2.  Fast track surgery versus conventional recovery strategies for colorectal surgery.

Authors:  Willem R Spanjersberg; Jurrian Reurings; Frederik Keus; Cornelis Jhm van Laarhoven
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

3.  Clinical practice guideline for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

Authors:  Joseph C Carmichael; Deborah S Keller; Gabriele Baldini; Liliana Bordeianou; Eric Weiss; Lawrence Lee; Marylise Boutros; James McClane; Scott R Steele; Liane S Feldman
Journal:  Surg Endosc       Date:  2017-08-03       Impact factor: 4.584

4.  "Ultra" E.R.A.S. in laparoscopic colectomy for cancer: discharge after the first flatus? A prospective, randomized trial.

Authors:  Gianluca Garulli; Andrea Lucchi; Pierluigi Berti; Carlo Gabbianelli; Luca Maria Siani
Journal:  Surg Endosc       Date:  2016-08-12       Impact factor: 4.584

5.  Role of Adherence to Enhanced Recovery After Surgery Programs in Mitigating Healthcare Disparities-Reply.

Authors:  Javier Ripollés-Melchor; José M Ramírez-Rodríguez; César Aldecoa
Journal:  JAMA Surg       Date:  2020-01-01       Impact factor: 14.766

6.  Enhanced recovery pathways in colorectal surgery: a consensus paper by the Associazione Chirurghi Ospedalieri Italiani (ACOI) and the PeriOperative Italian Society (POIS).

Authors:  F Ficari; F Borghi; M Catarci; M Scatizzi; V Alagna; I Bachini; G Baldazzi; U Bardi; M Benedetti; L Beretta; E Bertocchi; D Caliendo; R Campagnacci; A Cardinali; M Carlini; M Cascella; D Cassini; S Ciotti; A Cirio; P Coata; D Conti; P DelRio; C Di Marco; L Ferla; C Fiorindi; G Garulli; C Genzano; G Guercioni; B Marra; A Maurizi; R Monzani; U Pace; L Pandolfini; A Parisi; M Pavanello; N Pecorelli; Luigi Pellegrino; R Persiani; F Pirozzi; B Pirrera; A Rizzo; M Rolfo; S Romagnoli; G Ruffo; A Sciuto; P Marini
Journal:  G Chir       Date:  2019 Jul-Aug

7.  Effects of implementing a care pathway for colorectal cancer surgery in ten European hospitals: an international multicenter pre-post-test study.

Authors:  Ruben van Zelm; Ellen Coeckelberghs; Walter Sermeus; Albert Wolthuis; Luk Bruyneel; Massimiliano Panella; Kris Vanhaecht
Journal:  Updates Surg       Date:  2020-01-28
  7 in total
  3 in total

1.  ERAS program adherence-institutionalization, major morbidity and anastomotic leakage after elective colorectal surgery: the iCral2 multicenter prospective study.

Authors:  Marco Catarci; Giacomo Ruffo; Massimo Giuseppe Viola; Felice Pirozzi; Paolo Delrio; Felice Borghi; Gianluca Garulli; Gianandrea Baldazzi; Pierluigi Marini; Giuseppe Sica
Journal:  Surg Endosc       Date:  2021-09-14       Impact factor: 3.453

2.  Preoperative Immunonutrition vs. Standard Dietary Advice in Normo-Nourished Patients Undergoing Fast-Track Laparoscopic Colorectal Surgery.

Authors:  Manfredi Tesauro; Andrea M Guida; Leandro Siragusa; Bruno Sensi; Vittoria Bellato; Nicola Di Daniele; Andrea Divizia; Marzia Franceschilli; Giuseppe S Sica
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

3.  ERas and COLorectal endoscopic surgery: an Italian society for endoscopic surgery and new technologies (SICE) national report.

Authors:  Marco Milone; Ugo Elmore; Michele Manigrasso; Monica Ortenzi; Emanuele Botteri; Alberto Arezzo; Gianfranco Silecchia; Mario Guerrieri; Giovanni Domenico De Palma; Ferdinando Agresta
Journal:  Surg Endosc       Date:  2022-05-02       Impact factor: 3.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.